Palantirs, Military

Palantir's Military Momentum Faces Its Most Contradictory Moment Yet

Published on 09/01/2026 at 12:22 | Editorial boerse-global.de

Palantir secures defense contracts and raises guidance, but CEO Karp's $86M stock sale and high valuation temper the bull case.

Extreme Makro-Aufnahme eines Glasfaserkabel-BĂĽndels mit leuchtenden blauen Lichtpunkten auf schwarzem Hintergrund
Palantir Technologies Inc (US69608A1088) – extreme Makro-Nahaufnahme leuchtender Glasfaserkabel-Bündel mit brillanten Lichtpunkten in Blau Illustration mit AI erstellt.

The bull case for Palantir has never been easier to articulate — and never harder to square with what its own executives are doing. Over the past week, the company has stacked up defense contracts, expanded its commercial partnerships, and drawn fresh analyst endorsements, all while its chief executive quietly liquidated a nine-figure stake.

The tension is not lost on the market. The stock sits roughly 11 percent below its 52-week high of 179.98 euros, despite a 30-day gain of 47 percent and annualized volatility near 99 percent. Investors are paying a premium for momentum, but the signals underneath are increasingly mixed.

The Pentagon Pipeline Keeps Growing

The most concrete development came on August 25, when Palantir and Raytheon jointly secured a contract ceiling of $876 million for the Army's Distributed Common Ground System. That same day, the company reported a record remaining deal value of $13.1 billion for the second quarter of 2026 — a figure that arrived alongside media reports of a potential $875 million contract loss, apparently tied to the FAA. The juxtaposition is instructive: Palantir is losing business, but it is replacing it faster than it can be taken away.

The centerpiece of the defense thesis remains Maven, the Pentagon's AI program that began as an image-recognition project. William Blair analyst Louie DiPalma, who initiated coverage with a Buy rating on August 26, pegged Maven's potential at up to $1 billion in annual recurring revenue. The following day, the firm highlighted the Army's expansion of the Maven Smart System contract to as much as $1.3 billion over five years — a figure that has become the anchor point for the entire bull narrative.

Not everyone is cheering. On August 27, members of National Nurses United staged protests in eight U.S. cities over Palantir's government and healthcare contracts, citing privacy and ethics concerns. The demonstrations do nothing to alter the order book, but they serve as a reminder that the company's business model carries political baggage that few peers can match.

Should investors sell immediately? Or is it worth buying Palantir?

Commercial Diversification Moves Forward

Palantir is not content to live on defense alone. On August 28, the company announced two partnerships aimed at broadening its commercial footprint: a collaboration with Mercury Systems to embed AI software into supply-chain and manufacturing processes for U.S. military programs, and a tie-up with Snowflake linking Palantir Foundry and AIP to the Snowflake AI Data Cloud for enterprise-scale applications. Both read as deliberate attempts to reduce reliance on the Pentagon.

The commercial engine is already showing signs of life. In the second quarter, U.S. government revenue grew 90 percent to $809 million, while U.S. commercial revenue expanded even faster — up 149 percent to $764 million. Company-wide, revenue climbed 93 percent to $1.94 billion, with net income reaching $1.06 billion, or $0.41 per share, against $0.13 in the year-ago quarter.

Management responded by lifting full-year guidance to $8.15–$8.158 billion in revenue, with U.S. commercial growth projected above 134 percent. The third-quarter outlook calls for revenue of $2.160–$2.164 billion and adjusted operating income of $1.292–$1.296 billion. CEO Alexander Karp described the quarter to CNBC as "otherworldly," arguing that demand for AI sovereignty has been unleashed and predicting the growth pace could persist for at least 18 months — a statement he framed explicitly as an expectation, not a promise.

Wall Street Splits on the Price

The analyst community has responded with a mix of enthusiasm and caution. UBS raised its price target to $220 in late August, and Bank of America reportedly moved to $255. Simply Wall St noted on August 26 that the consensus target had been lifted from $182 to $192, supported by a 12 percent increase in fiscal 2026 earnings estimates.

But the optimists do not have the floor to themselves. Seeking Alpha analyst Juxtaposed Ideas downgraded the stock from Buy to Hold on August 18, citing an overextended valuation following the post-earnings rally. That caution is not necessarily a contradiction of the bullish price targets — it is their necessary complement. Even those who believe in the operational momentum must reckon with what the market already charges for it.

The stock's technical picture reinforces the ambivalence. After closing at 160.66 euros on Monday, shares slipped 1.8 percent to 157.78 euros. The 30-day gain of 44 percent leaves the stock about 12 percent below its November 3 high of 179.98 euros, with a relative strength index of 68.9 signaling a decidedly warm buying dynamic.

Palantir at a turning point? This analysis reveals what investors need to know now.

The Insider Selling Question

Then there is the matter of who is selling. Karp disposed of roughly 492,000 shares on August 20 at an average price of $174.79 — approximately $86 million in total — according to a regulatory filing under a Rule 10b5-1 plan designed to cover tax obligations. That followed earlier sales in May, when Karp and technology chief Shyam Sankar together sold shares worth $43 million. Cathie Wood's ARK Invest also trimmed its position in late August, selling $27.2 million worth of Palantir stock while buying SpaceX shares of similar value.

Automated selling plans are legally clean and common for executives with large equity stakes. But the optics are hard to ignore: a chief executive cashing out during a period of euphoric price targets, record guidance, and an escalating rally.

The next test arrives November 2, when the company reports third-quarter results. Analysts expect earnings per share of $0.40 — a number that will show whether Karp's promised growth trajectory has real staying power. For now, the fundamentals and the stock price are telling two different stories, and investors holding Palantir would do well to keep them separate.

Ad

Palantir Stock: New Analysis - 1 September

Fresh Palantir information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Palantir analysis...

Disclaimer...

en | US69608A1088 | PALANTIRS | boerse | 70035504 |